2010-03-10 20:27:15 -
Benitec Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/benitec-ltd. ..
Benitec Ltd. (Benitec) is a research focused biotechnology company engaged in development of innovative pharmaceuticals for the treatment of serious life threatening diseases. The company has developed its proprietary DNA-directed RNA interference (ddRNAi) technology for the development of human therapeutics to precisely destroy RNA viruses and silence the expression of defective genes. The company develops treatments for Hepatitis C and HIV in collaboration with some pharmaceutical companies. The company is headquartered at Melbourne, Australia.
And More inside the report
Recent Developments
Feb 05, 2010: Benitec Licensee Achieves Milestone With Pfizer
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys
major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings, partnerships and licensing agreements.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
